539 related articles for article (PubMed ID: 32038653)
21. CD4 T cell immunity is critical for the control of simian varicella virus infection in a nonhuman primate model of VZV infection.
Haberthur K; Engelmann F; Park B; Barron A; Legasse A; Dewane J; Fischer M; Kerns A; Brown M; Messaoudi I
PLoS Pathog; 2011 Nov; 7(11):e1002367. PubMed ID: 22102814
[TBL] [Abstract][Full Text] [Related]
22. [Varicella-zoster virus (VZV)].
Kanai K; Yamada S; Inoue N
Uirusu; 2010 Dec; 60(2):197-207. PubMed ID: 21488333
[TBL] [Abstract][Full Text] [Related]
23. A systematic approach for the identification of novel, serologically reactive recombinant Varicella-Zoster Virus (VZV) antigens.
Vizoso Pinto MG; Pfrepper KI; Janke T; Noelting C; Sander M; Lueking A; Haas J; Nitschko H; Jaeger G; Baiker A
Virol J; 2010 Jul; 7():165. PubMed ID: 20646309
[TBL] [Abstract][Full Text] [Related]
24. Identification of an important immunological difference between virulent varicella-zoster virus and its avirulent vaccine: viral disruption of dendritic cell instruction.
Gutzeit C; Raftery MJ; Peiser M; Tischer KB; Ulrich M; Eberhardt M; Stockfleth E; Giese T; Sauerbrei A; Morita CT; Schönrich G
J Immunol; 2010 Jul; 185(1):488-97. PubMed ID: 20525895
[TBL] [Abstract][Full Text] [Related]
25. Advances in the treatment of varicella-zoster virus infections.
Andrei G; Snoeck R
Adv Pharmacol; 2013; 67():107-68. PubMed ID: 23886000
[TBL] [Abstract][Full Text] [Related]
26. Prevalence of a history of prior varicella/herpes zoster infection in multiple sclerosis.
Manouchehrinia A; Tanasescu R; Kareem H; Jerca OP; Jabeen F; Shafei R; Breuer J; Neal K; Irving W; Constantinescu CS
J Neurovirol; 2017 Dec; 23(6):839-844. PubMed ID: 28895088
[TBL] [Abstract][Full Text] [Related]
27. Varicella-zoster virus T cell tropism and the pathogenesis of skin infection.
Arvin AM; Moffat JF; Sommer M; Oliver S; Che X; Vleck S; Zerboni L; Ku CC
Curr Top Microbiol Immunol; 2010; 342():189-209. PubMed ID: 20397071
[TBL] [Abstract][Full Text] [Related]
28. Varicella zoster virus: natural history and current therapies of varicella and herpes zoster.
Breuer J; Whitley R
Herpes; 2007 Sep; 14 Suppl 2():25-9. PubMed ID: 17939892
[TBL] [Abstract][Full Text] [Related]
29. Differentiation of wild-type varicella-zoster strains from India and the Oka vaccine strain using a VZV open reading frame - 62 based PCR-RFLP technique.
Kaushik KS; Lahiri KK; Kapila K; Kumar S; Gupta RM; Karade S
Braz J Infect Dis; 2008 Aug; 12(4):313-5. PubMed ID: 19030732
[TBL] [Abstract][Full Text] [Related]
30. Molecular studies of Varicella zoster virus.
Quinlivan M; Breuer J
Rev Med Virol; 2006; 16(4):225-50. PubMed ID: 16791838
[TBL] [Abstract][Full Text] [Related]
31. Investigation of varicella-zoster virus-infected cell proteins that elicit antibody production during primary varicella using the immune transfer method.
Palumbo PE; Arvin AM; Koropchak CM; Wittek AE
J Gen Virol; 1984 Dec; 65 ( Pt 12)():2141-7. PubMed ID: 6096492
[TBL] [Abstract][Full Text] [Related]
32. Antibodies to the three major glycoproteins of varicella-zoster virus: search for the relevant host immune response.
Brunell PA; Novelli VM; Keller PM; Ellis RW
J Infect Dis; 1987 Sep; 156(3):430-5. PubMed ID: 3039010
[TBL] [Abstract][Full Text] [Related]
33. Utility of ultra-deep sequencing for detection of varicella-zoster virus antiviral resistance mutations.
Mercier-Darty M; Boutolleau D; Lepeule R; Rodriguez C; Burrel S
Antiviral Res; 2018 Mar; 151():20-23. PubMed ID: 29337163
[TBL] [Abstract][Full Text] [Related]
34. Clinical and molecular pathogenesis of varicella virus infection.
Gilden DH; Cohrs RJ; Mahalingam R
Viral Immunol; 2003; 16(3):243-58. PubMed ID: 14583142
[TBL] [Abstract][Full Text] [Related]
35. Varicella-zoster virus and virus DNA in the blood and oropharynx of people with latent or active varicella-zoster virus infections.
Levin MJ
J Clin Virol; 2014 Dec; 61(4):487-95. PubMed ID: 25453570
[TBL] [Abstract][Full Text] [Related]
36. Varicella zoster vaccines and their implications for development of HSV vaccines.
Gershon AA
Virology; 2013 Jan; 435(1):29-36. PubMed ID: 23217613
[TBL] [Abstract][Full Text] [Related]
37. Antibody to early antigens of varicella-zoster virus during varicella and zoster.
Gerna G; Cereda PM; Cattaneo E; Achilli G; Gerna MT
J Infect Dis; 1979 Jul; 140(1):33-41. PubMed ID: 88490
[TBL] [Abstract][Full Text] [Related]
38. Upregulation of CXCL10 in human dorsal root ganglia during experimental and natural varicella-zoster virus infection.
Steain M; Gowrishankar K; Rodriguez M; Slobedman B; Abendroth A
J Virol; 2011 Jan; 85(1):626-31. PubMed ID: 20980518
[TBL] [Abstract][Full Text] [Related]
39. Congenital varicella-zoster virus infection and the failure to establish virus-specific cell-mediated immunity.
Grose C
Mol Biol Med; 1989 Oct; 6(5):453-62. PubMed ID: 2560525
[TBL] [Abstract][Full Text] [Related]
40. Molecular mechanisms of varicella zoster virus pathogenesis.
Zerboni L; Sen N; Oliver SL; Arvin AM
Nat Rev Microbiol; 2014 Mar; 12(3):197-210. PubMed ID: 24509782
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
